MAPS Trial: Matrix And Platinum Science "MAPS"

Completed

Phase 4 Results

Summary of Purpose

Primary Objectives: - To establish Target Aneurysm Recurrence (TAR) rates for Matrix 2® and GDC® Coils used for the treatment of intracranial saccular aneurysms. TAR is defined as clinically relevant recurrence resulting in: target aneurysm reintervention, rupture/re-rupture and/or death from an unknown cause. - To correlate defined angiographic endpoints with TAR rates and assess...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 January 2016.

1 Mar 2007 6 Nov 2006 1 Jan 2011 1 Mar 2015 1 Jan 2016 7 Feb 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • David Hess Ph: 510-440-7749

    David.Hess@bsci.com